JP2023510258A5 - - Google Patents
Info
- Publication number
- JP2023510258A5 JP2023510258A5 JP2022541814A JP2022541814A JP2023510258A5 JP 2023510258 A5 JP2023510258 A5 JP 2023510258A5 JP 2022541814 A JP2022541814 A JP 2022541814A JP 2022541814 A JP2022541814 A JP 2022541814A JP 2023510258 A5 JP2023510258 A5 JP 2023510258A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- free
- solution
- pharmaceutical composition
- mosmo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025175228A JP2026016486A (ja) | 2020-01-10 | 2025-10-17 | 安定なシクロデキストリン不含カルフィルゾミブ処方物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062959829P | 2020-01-10 | 2020-01-10 | |
| US62/959,829 | 2020-01-10 | ||
| PCT/US2021/012826 WO2021142360A1 (en) | 2020-01-10 | 2021-01-08 | Stable cyclodextrin free carfilzomib formulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025175228A Division JP2026016486A (ja) | 2020-01-10 | 2025-10-17 | 安定なシクロデキストリン不含カルフィルゾミブ処方物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023510258A JP2023510258A (ja) | 2023-03-13 |
| JP2023510258A5 true JP2023510258A5 (enExample) | 2024-01-16 |
Family
ID=74626106
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022541814A Pending JP2023510258A (ja) | 2020-01-10 | 2021-01-08 | 安定なシクロデキストリン不含カルフィルゾミブ処方物 |
| JP2025175228A Pending JP2026016486A (ja) | 2020-01-10 | 2025-10-17 | 安定なシクロデキストリン不含カルフィルゾミブ処方物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025175228A Pending JP2026016486A (ja) | 2020-01-10 | 2025-10-17 | 安定なシクロデキストリン不含カルフィルゾミブ処方物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250345384A1 (enExample) |
| EP (1) | EP4087538A1 (enExample) |
| JP (2) | JP2023510258A (enExample) |
| CN (1) | CN115279339A (enExample) |
| WO (1) | WO2021142360A1 (enExample) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340736A (en) | 1991-05-13 | 1994-08-23 | The President & Fellows Of Harvard College | ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
| AU4499697A (en) | 1996-09-13 | 1998-04-02 | New York University | Method for treating parasitic diseases with proteasome inhibitors |
| ES2637113T3 (es) * | 2011-01-10 | 2017-10-10 | Infinity Pharmaceuticals, Inc. | Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas |
| MY196510A (en) * | 2012-05-08 | 2023-04-18 | Onyx Therapeutics Inc | Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors |
| AU2013337717B2 (en) * | 2012-11-01 | 2018-10-25 | Infinity Pharmaceuticals, Inc. | Treatment of cancers using PI3 kinase isoform modulators |
| ES2648367T3 (es) * | 2013-10-22 | 2018-01-02 | Medac Gesellschaft für klinische Spezialpräparate mbH | Procedimiento de preparación de una composición farmacéutica liofilizada que contiene mitomicina C |
| WO2015198257A1 (en) * | 2014-06-26 | 2015-12-30 | Intas Pharmaceuticals Ltd. | Stable carfilzomib injection |
| CA2966288A1 (en) * | 2014-10-30 | 2016-05-06 | Big Dna Ltd | Combination therapy |
| WO2016116882A2 (en) * | 2015-01-23 | 2016-07-28 | Leiutis Pharmaceuticals Pvt Ltd | Novel compositions of carfilzomib |
| TWI759301B (zh) * | 2016-05-24 | 2022-04-01 | 美商安美基公司 | 聚乙二醇化卡非佐米化合物 |
-
2021
- 2021-01-08 CN CN202180020091.3A patent/CN115279339A/zh active Pending
- 2021-01-08 US US17/810,136 patent/US20250345384A1/en active Pending
- 2021-01-08 EP EP21705680.3A patent/EP4087538A1/en active Pending
- 2021-01-08 JP JP2022541814A patent/JP2023510258A/ja active Pending
- 2021-01-08 WO PCT/US2021/012826 patent/WO2021142360A1/en not_active Ceased
-
2025
- 2025-10-17 JP JP2025175228A patent/JP2026016486A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5936546B2 (ja) | ６−フルオロ−３−ヒドロキシ−２−ピラジンカルボキサミドのメグルミン塩 | |
| JP6869941B2 (ja) | ある含有量のマイトマイシンｃを有する凍結乾燥医薬組成物を製造する方法 | |
| JP2010163443A (ja) | ジデムニン（Ｄｉｄｅｍｎｉｎ）化合物の医薬製剤 | |
| CN110876259B (zh) | 注射用组合物 | |
| CN101984968A (zh) | 抗肿瘤剂替莫唑胺的药物制剂制备方法 | |
| WO2016059590A1 (en) | Stable injectable composition of small molecule drugs and process for its preparation | |
| JP2007500191A (ja) | Ｃｃｉ−７７９の凍結乾燥処方 | |
| CN102512404A (zh) | 一种姜黄素类化合物肺靶向制剂及其制备方法与应用 | |
| JP4142149B2 (ja) | バンコマイシンの凍結乾燥製剤 | |
| KR101468153B1 (ko) | 5α-안드로스테인-3β,5,6β-트리올 주사제 및 제조방법 | |
| JP5723031B2 (ja) | エキノカンジン系抗真菌剤であるミカファンギンを含む液体薬用組成物 | |
| JP5070670B2 (ja) | Ｎ−［ｏ−（ｐ−ピバロイルオキシベンゼンスルホニルアミノ）ベンゾイル］グリシン・モノナトリウム塩・４水和物の凍結乾燥製剤およびその製造方法 | |
| JP6165986B2 (ja) | ボルテゾミブを含む医薬組成物 | |
| JP6063064B2 (ja) | 安定したノカチアシン凍結乾燥製剤 | |
| JP2023510258A5 (enExample) | ||
| CN101378759A (zh) | 三唑并嘧啶化合物的冻干组合物 | |
| JPWO2002007724A1 (ja) | Ｎ−［ｏ−（ｐ−ピバロイルオキシベンゼンスルホニルアミノ）ベンゾイル］グリシン・モノナトリウム塩・４水和物の凍結乾燥製剤およびその製造方法 | |
| JP2026016486A5 (enExample) | ||
| JP7317804B2 (ja) | ドセタキセル結合体の医薬組成物及び調製方法 | |
| JP2012501331A (ja) | カンフォスファミド製剤及びその製造方法 | |
| JP2026505092A (ja) | 注射用組成物、それを含む医薬製剤及びその製造方法 | |
| CN115038431B (zh) | 达托霉素制剂 | |
| JP2020535143A (ja) | シポニモドを含む非経口製剤 | |
| CN117281813A (zh) | 一种瑞马唑仑的药物组合物 | |
| CN101669916A (zh) | 一种硝苯地平冻干粉针的制备方法 |